Lipocine Inc. (LPCN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 43.75M |
| Enterprise Value | 39M |
| P/E Ratio | -0.86 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 8.4 |
| Price/Book Ratio | 0.6 |
| Enterprise/Revenue | 5.23 |
| Enterprise/EBITDA | -0.7 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -7.55 |
| Operating Margin | -8.01 |
AD
Management Effectiveness
| Return On Assets | -0.5 |
| Return On Equity | -0.65 |
Income Statement
| Revenue | 1.98M |
| Revenue/Share | 0.19 |
| Gross Profit | -6.61M |
| EBITDA | -9.57M |
| Net Income | -9.63M |
| Diluted EPS | -1.69 |
Balance Sheet
| Total Cash | 23.27M |
| Total Cash/Share | 2.83 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 11.48 |
| Book Value Per Share | 2.65 |
Price History
| 52-Week Change | -43.06 |
| 52-Week High | 12.37 |
| 52-Week Low | 1.4 |
| Moving Average 50 Days | 2.07 |
| Moving Average 200 Days | 4.17 |
Statistics
| Average Volume | 1.76M |
| Shares Outstanding | 8.24M |
| % Held by Institutions | 36.27 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:17 |
| Last Split Date | May 12, 2023 |
AD
